Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke - PubMed (original) (raw)
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
Li Hong Shen et al. J Cereb Blood Flow Metab. 2007 Jan.
Abstract
Bone marrow stromal cells (BMSCs) facilitate functional recovery in rats after stroke when administered acutely (1 day) or subacutely (7 days). In this study, we postponed the time of cell transplantation to 1 month after stroke. Female retired breeder rats were subjected to 2 h of middle cerebral artery occlusion (MCAo). Male BMSCs (3 x 10(6)) or phosphate-buffered saline were administered intravenously, and the animals were killed 3 months later. An additional population of nontreated rats was killed at 1 month after MCAo. Significant recovery of behavior was found in BMSC-treated rats beginning at 1 month after cell injection in the modified neurologic severity score test and the adhesive-removal test compared with control animals (P<0.05). In situ hybridization showed that BMSCs survived and preferentially localized to the ipsilateral hemisphere. Double staining revealed that approximately 13% and 6% Y-chromosome-positive cells expressed the astrocyte marker, glial fibrillary acidic protein, and the neuronal marker, microtubule-associated protein-2, respectively. In addition, BMSC treatment reduced scar thickness, and increased the number of proliferating cells and oligodendrocyte precursor cells along the subventricular zone in the ipsilateral hemisphere. Expression of the chemokine stromal-cell-derived factor-1 (SDF-1) was significantly increased along the ischemic boundary zone compared with the corresponding areas in the contralateral hemisphere at 1 month and 4 months (P<0.01) after stroke. The SDF-1 receptor, CXC-chemokine receptor-4 (CXCR4), was expressed in BMSCs both in vitro and in vivo. Our data show that the time window of BMSC therapy is at least 1 month after stroke; the interaction of SDF-1/CXCR4 may contribute to the trafficking of transplanted BMSCs.
Similar articles
- One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke.
Shen LH, Li Y, Chen J, Cui Y, Zhang C, Kapke A, Lu M, Savant-Bhonsale S, Chopp M. Shen LH, et al. Stroke. 2007 Jul;38(7):2150-6. doi: 10.1161/STROKEAHA.106.481218. Epub 2007 May 24. Stroke. 2007. PMID: 17525391 - Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.
Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. Chen J, et al. J Neurosci Res. 2003 Sep 15;73(6):778-86. doi: 10.1002/jnr.10691. J Neurosci Res. 2003. PMID: 12949903 - SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model.
Wang Y, Deng Y, Zhou GQ. Wang Y, et al. Brain Res. 2008 Feb 21;1195:104-12. doi: 10.1016/j.brainres.2007.11.068. Epub 2007 Dec 14. Brain Res. 2008. PMID: 18206136 - Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.
Cui X, Chen J, Zacharek A, Li Y, Roberts C, Kapke A, Savant-Bhonsale S, Chopp M. Cui X, et al. Stem Cells. 2007 Nov;25(11):2777-85. doi: 10.1634/stemcells.2007-0169. Epub 2007 Jul 19. Stem Cells. 2007. PMID: 17641243 Free PMC article.
Cited by
- Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice.
Mora-Lee S, Sirerol-Piquer MS, Gutiérrez-Pérez M, Gomez-Pinedo U, Roobrouck VD, López T, Casado-Nieto M, Abizanda G, Rabena MT, Verfaille C, Prósper F, García-Verdugo JM. Mora-Lee S, et al. PLoS One. 2012;7(8):e43683. doi: 10.1371/journal.pone.0043683. Epub 2012 Aug 31. PLoS One. 2012. PMID: 22952736 Free PMC article. - The potential benefit of stem cell therapy after stroke: an update.
Banerjee S, Williamson DA, Habib N, Chataway J. Banerjee S, et al. Vasc Health Risk Manag. 2012;8:569-80. doi: 10.2147/VHRM.S25745. Epub 2012 Oct 10. Vasc Health Risk Manag. 2012. PMID: 23091389 Free PMC article. Review. - Cell-based therapy for ischemic stroke.
Zhang J, Chopp M. Zhang J, et al. Expert Opin Biol Ther. 2013 Sep;13(9):1229-40. doi: 10.1517/14712598.2013.804507. Epub 2013 Jun 6. Expert Opin Biol Ther. 2013. PMID: 23738646 Free PMC article. Review. - Regenerative cellular therapies for neurologic diseases.
Levy M, Boulis N, Rao M, Svendsen CN. Levy M, et al. Brain Res. 2016 May 1;1638(Pt A):88-96. doi: 10.1016/j.brainres.2015.06.053. Epub 2015 Jul 31. Brain Res. 2016. PMID: 26239912 Free PMC article. Review. - Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats.
Lee SH, Jin KS, Bang OY, Kim BJ, Park SJ, Lee NH, Yoo KH, Koo HH, Sung KW. Lee SH, et al. PLoS One. 2015 Aug 4;10(8):e0134920. doi: 10.1371/journal.pone.0134920. eCollection 2015. PLoS One. 2015. PMID: 26241653 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- P01 NS042345/NS/NINDS NIH HHS/United States
- R01 NS045041/NS/NINDS NIH HHS/United States
- P01 NS23393/NS/NINDS NIH HHS/United States
- R01 NS45041/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical